MYH2

protein-coding

myosin heavy chain 2, the group of Myosin heavy chains, class II

Gene summary

Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in inclusion body myopathy-3. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2009]

Previous symbols:
  • IBM3

MANE transcript

NM_017534.6

Inheritance

AR, SD, AD

ClinVar variants

P:133U:903B:366

Top phenotype

Congenital myopathy 6 with ophthalmoplegia

gnomAD constraint

pLI —, LoF o/e 0.55

Max pathogenic AF

—

Genomic locus

chr17:10,521,148-10,549,700

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~28.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

myopathy, proximal, and ophthalmoplegiaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0011577

Submitter: Laboratory for Molecular Medicine

This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.

childhood-onset autosomal recessive myopathy with external ophthalmoplegiaSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0018206

Submitter: Orphanet

myopathy, proximal, and ophthalmoplegiaSTRONG

Inheritance Pattern: SD

Disease ID:MONDO:0011577

Submitter: Ambry Genetics

myopathy, proximal, and ophthalmoplegiaDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0011577

Submitter: ClinGen

*MYH2* was first reported in relation to autosomal recessive proximal myopathy and ophthalmoplegia in 2000 (Tajsharghi et al., PMID: 20418530). Evidence supporting this gene-disease relationship includes case-level data from 8 probands in 3 publications (PMIDs: 20418530, 23388406, 24193343), with ten unique variants (including missense, in-frame deletions, frameshifts, and splice sites), having a loss of function mechanism. This gene-disease association is also supported by experimental evidence, including expression evidence (PMID: 7545970) in type IIa muscle fibers and a C. elegans model (PMID: 16130113). In summary, *MYH2* is definitively associated with autosomal recessive proximal myopathy and ophthalmoplegia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Of note, *MYH2* has also been reported in relation to autosomal dominant proximal myopathy and ophthalmoplegia. Due to the proposed difference in mechanism, dominant negative, those cases were considered in a separate curation.

myopathy, proximal, and ophthalmoplegiaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0011577

Submitter: PanelApp Australia

myopathy, proximal, and ophthalmoplegiaSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0011577

Submitter: Labcorp Genetics (formerly Invitae)

myopathy, proximal, and ophthalmoplegiaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0011577

Submitter: Labcorp Genetics (formerly Invitae)

myopathy, proximal, and ophthalmoplegiaSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0011577

Submitter: PanelApp Australia

hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndromeSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019195

Submitter: Orphanet

hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndromeLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0019195

Submitter: Illumina

myopathy, proximal, and ophthalmoplegiaMODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0011577

Submitter: ClinGen

*MYH2* was first reported in relation to autosomal dominant proximal myopathy and ophthalmoplegia in 2000 (Martinsson et al., PMID: 11114175). Evidence supporting this gene-disease relationship includes case-level data from 7 probands in 6 publications (PMIDs: 11114175, 23489661, 25529940, 36380287, 36774715,41252304), with five unique variants (4 missense and 1 splice site) predominantly found in the filament assembly region except for Glu706Lys in the SH1 helix domain. A dominant negative mechanism has been suggested however has not been established. This gene-disease association is also supported by experimental evidence, including expression evidence (PMID: 7545970) in type IIa muscle fibers, functional alteration in patient cells (PMID: 17005402), and a C. elegans model (PMID: 16130113). In summary, there is moderate evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was originally evaluated by the Congenital Myopathies and Myasthenic Syndromes GCEP on June 10, 2024. It was re-evaluated on June 10, 2026. As a result of this reevaluation, the classification remained Moderate with the addition of 2 new cases (PMID: 41252304). Of note, *MYH2* has also been reported in relation to autosomal recessive proximal myopathy and ophthalmoplegia. Due to the proposed difference in mechanism, loss of function, those cases were considered in a separate curation.

Clinical Genomic Database (CGD)

Congenital myopathy 6 with ophthalmoplegiaAD/AR

Manifestation: Musculoskeletal

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 11114175; 24193343Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to MYH2 variants in ClinVar

14 Conditions Cataloged
Myopathy, proximal, and ophthalmoplegiaTotal: 1449
not providedTotal: 269
Inborn genetic diseasesTotal: 254
MYH2-related disorderTotal: 49
not specifiedTotal: 48
MyopathyTotal: 2
Childhood-onset autosomal recessive myopathy with external ophthalmoplegiaTotal: 1
Hereditary spherocytosis type 2Total: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_017534.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
21
clinvar
333
clinvar
5
clinvar
359
missense
3
clinvar
7
clinvar
873
clinvar
26
clinvar
2
clinvar
911
nonsense
24
clinvar
13
clinvar
2
clinvar
39
start loss
3
clinvar
3
frameshift
37
clinvar
15
clinvar
4
clinvar
56
splice donor/acceptor (+/-2bp)
4
clinvar
30
clinvar
34
Total686590335971402

Highest pathogenic variant AF is 0.000065672575

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 28 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_017534.6RefSeqNP_060004.338MANE Select
ENST00000245503.10EnsemblENSP00000245503.538MANE Select
NM_001100112.2RefSeqNP_001093582.138Standard
ENST00000397183.6EnsemblENSP00000380367.238Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Tight junction - Homo sapiens (human)
  • amb2 Integrin signaling
  • Alpha4 beta1 integrin signaling events

Biological Process

  • muscle contraction
  • muscle filament sliding
  • Fc-gamma receptor signaling pathway involved in phagocytosis

Molecular Function

  • microfilament motor activity
  • protein binding
  • calmodulin binding
  • ATP binding
  • actin filament binding

Cellular Component

  • cytosol
  • muscle myosin complex
  • myofibril
  • sarcomere
  • myosin filament

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000245503
Coding exons
38
Length
28810
Individuals with no LoFs
125566
Homozygous LoFs
0
Heterozygous LoFs
182
Defined
125748
p
0.000724
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.978261.00e+30.8250.000059912909
Missense (PolyPhen)254325.40.780594458
Synonymous-0.6934043871.040.00002283539
Loss of Function4.155397.10.5460.000005271244

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.000980.00093rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.000710.00071rare
Finnish0.00170.0017notable
European (Non-Finnish)0.000590.00057rare
South Asian0.000880.00088rare
Other0.000490.00049rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Muscle contraction. Required for cytoskeleton organization (By similarity). {ECO:0000250}.;
Disease
DISEASE: Myopathy, proximal, and ophthalmoplegia (MYPOP) [MIM:605637]: A muscular disorder characterized by mild-to- moderate muscle weakness, ophthalmoplegia, and contractures at birth in some patients. Muscle biopsies from patients show predominance of type 1 fibers and small or absent type 2A fibers. The disease is non-progressive or it progresses very slowly. Inheritance is autosomal dominant or recessive. {ECO:0000269|PubMed:11114175}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.231

Intolerance Scores

LoFtool
0.0360
RVIS EVS
-2.09
RVIS percentile EVS
1.57

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.611

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.